The United Laboratories International Holdings ( (HK:3933) ) has provided an announcement.
The United Laboratories International Holdings Limited has announced that its board of directors will hold a meeting on March 24, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. The meeting will also discuss the recommendation of a final dividend, if any, which could have implications for stakeholders regarding the company’s financial health and future dividend policies.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It is primarily involved in the production and distribution of pharmaceutical products, focusing on both domestic and international markets.
YTD Price Performance: 9.21%
Average Trading Volume: 16,750
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.38B
Find detailed analytics on 3933 stock on TipRanks’ Stock Analysis page.